News archive.
Earlier AI news and analysis, kept for reference. Current coverage lives in News & Analysis.
Timed light and fasting speed stroke recovery in mice, study finds
A University of Rochester study in the Journal of Clinical Investigation shows circadian rhythm interventions improved motor recovery and reduced brain inflammation in stroke models. Here's what works beyond the acute window.
Health Systems That Skip Interop Will Be Acquired or Fail
CMS interoperability rules and agentic AI are forcing healthcare to abandon legacy systems now. Health leaders betting on static architecture risk extinction.
J&J expands multiple myeloma drug to earlier disease stages
Talvey combined with Darzalex Faspro showed efficacy in earlier-stage multiple myeloma, expanding J&J's immunotherapy candidate beyond current approved use. The data supports a broader patient population strategy.
Lilly's JAK drug shows promise in hard-to-treat myelofibrosis
Eli Lilly reported early positive results for a JAK inhibitor acquired through its Ajax purchase. The drug targets myelofibrosis patients and could compete with Incyte's established Jakafi.
Medicare eyes Keytruda, Opdivo price cuts by closing IV-to-injection loophole
Starting in 2029, Medicare's drug price negotiation rule may eliminate protections for medicines switching from intravenous to under-the-skin delivery, potentially lowering prices on two blockbuster cancer drugs.
Dexcom's OTC glucose sensor now cleared for kids as young as two
Dexcom's Stelo glucose monitor received FDA clearance to serve children ages 2 and up, expanding the market for over-the-counter continuous glucose monitoring beyond adults for the first time.
Judge blocks most of CMS ACA enrollment rule, but GOP bill keeps parts alive
A federal judge vacated most provisions of a 2025 CMS rule tightening ACA enrollment and eligibility. Insurance advocates won, but provisions already codified in GOP legislation remain enforceable.
Medicare targets cancer drug loophole in 2029 price negotiation rule
Starting 2029, Medicare plans to close a protection that shields intravenous-to-subcutaneous drug transitions from price controls. Immunotherapies like Opdivo and Keytruda could face negotiation for the first time.
Gartner names Cigati Solutions top competitor in productivity collaboration
Gartner Peer Insights ranked Cigati Solutions among leading alternatives in the 2026 productivity and collaboration category. See how it stacks against peers and what buyers report.
Gartner Names Top Cigati Solutions Strengths and Gaps for 2026
Gartner's latest assessment of Cigati Solutions reveals specific capabilities customers value and friction points holding back adoption. Here's what's working and what still needs work.
Gartner Names Top 5 Data Trends for 2025: What Your Team Needs
Gartner released its annual data and analytics trends report. Here are the five priorities analysts say will shape enterprise deployments this year.
Gartner Names Top 5 AI Vendors for Governance and Trust in CTI
Gartner released its ranking of five leading vendors for AI governance and trust capabilities within cyberthreat intelligence. See who made the cut and what sets them apart.